InvestorsHub Logo
Followers 137
Posts 22867
Boards Moderated 0
Alias Born 04/08/2004

Re: Amatuer17 post# 204298

Saturday, 11/18/2017 10:06:02 PM

Saturday, November 18, 2017 10:06:02 PM

Post# of 402731
Short selling biotech stocks like IPIX is immoral

https://www.statnews.com/2017/07/20/martin-shkreli-short-selling-biotech-stocks/

Investing allows for a win win win win relationship including the patients with the diseases and/or conditions, the stockholders, the doctors, the insurance companies, the USA, etc.


Innovation has developed three lead drug candidates—each with first-in-class potential across multiple clinical indications attributable to novel mechanisms of action—with dermatology, oncology, anti-inflammatory and antibiotic applications.

Prurisol—an orally-delivered medicine for treating psoriasis
Kevetrin—a non-genotoxic anti-cancer drug that modulates p53
Brilacidin—an immunomodulatory agent with anti-inflammatory/antibiotic properties
Based on sound science, and covered by strong intellectual property and patent protections, these drug candidates are in mid-to-late stage clinical trials.

Advancing under a number of special FDA designations to help expedite development, improve likelihood of drug approval and gain market exclusivity, they address large areas of unmet medical need and represent sizable commercial opportunities.



https://static1.squarespace.com/static/5715352e20c647639137f992/t/59c119f859cc6865d161a5b3/1505827323801/2017Sep+IPIX+Corporate+Overview.pdf

Good luck and GOD bless,

George













Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News